Chaudhuri A, Ghanim H, Arora P. Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: a review of pathophysiology, mechanisms, and evidence from recent trials. Diabetes Obes Metab. 2022;24:365–76.

Article  PubMed  Google Scholar 

Nakagawa O, Fujisawa K, Ishizaki T, et al. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 1996;392:189–93.

Article  CAS  PubMed  Google Scholar 

Sebbagh M, Renvoize C, Hamelin J, et al. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol. 2001;3:346–52.

Article  CAS  PubMed  Google Scholar 

Sebbagh M, Hamelin J, Bertoglio J, et al. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med. 2005;201:465–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagai Y, Matoba K, Takeda Y, et al. Rho-associated, coiled-coil-containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism. Kidney Int. 2022;102:536–45.

Article  CAS  PubMed  Google Scholar 

Matoba K, Takeda Y, Nagai Y, et al. ROCK2-induced metabolic rewiring in diabetic podocytopathy. Commun Biol. 2022;5:341.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matoba K, Nagai Y, Sekiguchi K, et al. Deletion of podocyte Rho-associated, coiled-coil-containing protein kinase 2 protects mice from focal segmental glomerulosclerosis. Commun Biol. 2024;7:402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi J, Wu X, Surma M, et al. Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis. 2013;4:e483.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matoba K, Takeda Y, Nagai Y, et al. The physiology, pathology, and therapeutic interventions for ROCK isoforms in diabetic kidney disease. Front Pharmacol. 2020;11:585633.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton. 2010;67:545–54.

Article  CAS  PubMed  Google Scholar 

Tanaka T, Nishimura D, Wu RC, et al. Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J Biol Chem. 2006;281:15320–9.

Article  CAS  PubMed  Google Scholar 

Matoba K, Kawanami D, Okada R, et al. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1alpha. Kidney Int. 2013;84:545–54.

Article  CAS  PubMed  Google Scholar 

Matoba K, Sekiguchi K, Nagai Y, et al. Renal ROCK activation and its pharmacological inhibition in patients with diabetes. Front Pharmacol. 2021;12:738121.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng F, Wu D, Gao B, et al. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease. Diabetes. 2008;57:1683–92.

Article  CAS  PubMed  Google Scholar 

Wang W, Wang Y, Long J, et al. Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells. Cell Metab. 2012;15:186–200.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manickam N, Patel M, Griendling KK, et al. RhoA/Rho kinase mediates TGF-beta1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am J Physiol Renal Physiol. 2014;307:F159–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matoba K, Kawanami D, Nagai Y, et al. Rho-kinase blockade attenuates podocyte apoptosis by inhibiting the Notch signaling pathway in diabetic nephropathy. Int J Mol Sci. 2017. https://doi.org/10.3390/ijms18081795.

Article  PubMed  PubMed Central  Google Scholar 

Komers R, Oyama TT, Beard DR, et al. Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats. Br J Pharmacol. 2011;162:163–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cavarape A, Bauer J, Bartoli E, et al. Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase. Nephrol Dial Transplant. 2003;18:1764–9.

Article  CAS  PubMed  Google Scholar 

Winaver J, Ovcharenko E, Rubinstein I, et al. Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure. Am J Physiol Heart Circ Physiol. 2006;290:H2007–14.

Article  CAS  PubMed  Google Scholar 

Dohi T, Miyauchi K, Ohkawa R, et al. Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. Clin Chim Acta. 2012;413:207–12.

Article  CAS  PubMed  Google Scholar 

Li HY, Oh YS, Choi JW, et al. Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice. Kidney Int. 2017;91(6):1362–73.

Article  CAS  PubMed  Google Scholar 

Takeda Y, Matoba K, Kawanami D, et al. Rock2 regulates monocyte migration and cell to cell adhesion in vascular endothelial cells. Int J Mol Sci. 2019. https://doi.org/10.3390/ijms20061331.

Article  PubMed  PubMed Central  Google Scholar 

Ishizawa S, Takahashi-Fujigasaki J, Kanazawa Y, et al. Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. Clin Exp Nephrol. 2014;18:844–52.

Article  CAS  PubMed  Google Scholar 

Matoba K, Kawanami D, Ishizawa S, et al. Rho-kinase mediates TNF-alpha-induced MCP-1 expression via p38 MAPK signaling pathway in mesangial cells. Biochem Biophys Res Commun. 2010;402:725–30.

Article  CAS  PubMed  Google Scholar 

Matoba K, Kawanami D, Tsukamoto M, et al. Rho-kinase regulation of TNF-alpha-induced nuclear translocation of NF-kappaB RelA/p65 and M-CSF expression via p38 MAPK in mesangial cells. Am J Physiol Renal Physiol. 2014;307:F571–80.

Article  CAS  PubMed  Google Scholar 

Juszczak F, Caron N, Mathew AV, et al. Critical role for AMPK in metabolic disease-induced chronic kidney disease. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21217994.

Article  PubMed  PubMed Central  Google Scholar 

Zhou L, Liu F, Huang XR, et al. Amelioration of albuminuria in ROCK1 knockout mice with streptozotocin-induced diabetic kidney disease. Am J Nephrol. 2011;34:468–75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagai Y, Matoba K, Kawanami D, et al. ROCK2 regulates TGF-beta-induced expression of CTGF and profibrotic genes via NF-kappaB and cytoskeleton dynamics in mesangial cells. Am J Physiol Renal Physiol. 2019;317:F839–51.

Article  CAS  PubMed  Google Scholar 

Feng Y, LoGrasso PV, Defert O, et al. Rho kinase (ROCK) inhibitors and their therapeutic potential. J Med Chem. 2016;59:2269–300.

Article